Kura Oncology (KURA) Change in Acquisitions & Divestments (2016 - 2026)

Kura Oncology (KURA) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $147.5 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 11.99% year-over-year to $147.5 million in Q1 2026; TTM through Mar 2026 was $735.0 million, a 17.47% increase from a year earlier, with the FY2025 full-year figure at $755.1 million, up 35.34% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $147.5 million, down from $177.5 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for KURA reached as high as $235.0 million in Q3 2025 and fell as low as $26.5 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $128.8 million across 5 years, with a median of $129.1 million in 2022.
• Across the five-year window, Change in Acquisitions & Divestments slumped 35.01% in 2022 and surged 220.91% in 2023, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $58.8 million in 2022, then jumped by 141.26% to $141.9 million in 2023, then advanced by 2.89% to $146.0 million in 2024, then gained by 21.58% to $177.5 million in 2025, then declined by 16.9% to $147.5 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $147.5 million in Q1 2026, $177.5 million in Q4 2025, and $235.0 million in Q3 2025.